| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PANDA | Human immunodeficiency virus type 1 (VSV-G-pseudotyped HIV-1 NL4-3) | MOI=Not provided;
72 hr |
Jurkat Human acute lymphoblastic leukemia cells | qPCR | 3 | Downregulation | p < 0.05 | Disease-related Human LncRNA Profiler (System Biosciences) | Not provided | 2013 | 23362321 |
| PANDA | Human immunodeficiency virus type 1 (VSV-G-pseudotyped HIV-1 NL4-3) | MOI=Not provided;
72 hr |
MT4Human T cell line | qPCR | 2 | Downregulation | p < 0.05 | Disease-related Human LncRNA Profiler (System Biosciences) | Not provided | 2013 | 23362321 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose